| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/05/2006 | CN1754542A Compound pharmaceutical composition for treating wind-warm lung-heat disease and its preparation method |
| 04/05/2006 | CN1754460A Pure soft-shelled turtle powder production method |
| 04/05/2006 | CN1754456A Dual-purpose tortoise tuckahoe serial product as food and medicine, and its preparation method |
| 04/05/2006 | CN1248740C AIDS virus vaccine with use of sendai virus vector |
| 04/05/2006 | CN1248735C Preparing method and usage of cardiotoxin |
| 04/05/2006 | CN1248730C Chinese medicine for treating enteritis |
| 04/05/2006 | CN1248727C Capsule for treating rheumatism and its manufacturing method |
| 04/05/2006 | CN1248726C Pharmaceutical composition for treating cancer and its preparation method |
| 04/05/2006 | CN1248724C Hair regenerating formulation and its production method |
| 04/05/2006 | CN1248723C Medicinal liquor for rheumatism and preparation method thereof |
| 04/05/2006 | CN1248712C Medicine composition for treating splenomegaly and its preparation method |
| 04/05/2006 | CN1248711C Chinese herbal medicine for treating hypertension |
| 04/05/2006 | CN1248710C Compound combined medicine capable of improving sleep quality and appetite and its producing method |
| 04/05/2006 | CN1248709C Chinese medicine preparation for stopping drug addiction |
| 04/05/2006 | CN1248707C Bone-setting medicine |
| 04/05/2006 | CN1248706C Pillworm application in preparation of medicine to treat osteoproliferation |
| 04/05/2006 | CN1248704C Spleen-fortifying qi-boosting capsule |
| 04/05/2006 | CN1248699C Method for preparing Chinese herb medicine freezing-drying power-injection for treating tumor |
| 04/05/2006 | CN1248694C Chinese medicine hair-growing head-membrane paste and its preparation method |
| 04/05/2006 | CN1248684C Chinese medicine powder for treating cardiovascular and cerebrovascular disease and preparing method thereof |
| 04/05/2006 | CN1248597C 林蛙油软胶囊 Rana oil capsules |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022775 Resins based on polystyrene-functionalized methyl esters groups of L-tyrosine and their uses |
| 04/04/2006 | US7022668 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 04/04/2006 | US7022666 administering leukemia inhibitory factor, and human cell growth factors such as tumor growth factors, fibroblast growth factors, and tissue inhibitors of metalloproease |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022348 Tissue engineering; biosynthesisl glutaraldehyde crosslinked collagen |
| 04/04/2006 | US7022347 Restorative and grafting material for hard tissue defects prepared from animal teeth |
| 04/04/2006 | US7022338 A pressed tablet was prepared in low pressure, no heat generated, with the help by adding oligosaccharides, polysaccharides, and adding slime-forming agent for targeting gastro-intestinal tract; Streptococcus, Lactobacillus, Bifidobacterium; stable viability; biodrugs |
| 04/04/2006 | US7022322 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 04/04/2006 | US7022319 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/04/2006 | CA2116138C Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 04/04/2006 | CA2037907C Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 03/30/2006 | WO2006034467A2 Biocompatible hydrogel compositions |
| 03/30/2006 | WO2006033999A2 Modified adenovirus containing a fiber replacement protein |
| 03/30/2006 | WO2006033951A1 Lactobacillus and atopobium compositions for maintaining and restoring normal gastrointestinal flora |
| 03/30/2006 | WO2006033950A1 Lactobacillus and atopobium compositions for maintaining and restoring normal urogenital flora |
| 03/30/2006 | WO2006033949A1 Lactobacillus iners for reduction of human malodor |
| 03/30/2006 | WO2006032542A1 Strain of lactobacillus acidophilus having analgesic properties in the gastrointestinal system |
| 03/30/2006 | WO2006032268A1 Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton |
| 03/30/2006 | WO2006032245A1 Pharmaceutical active ingredient against hiv - syndrome |
| 03/30/2006 | WO2006017417A9 Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins |
| 03/30/2006 | WO2006017374A3 Nutritional supplement composition and method |
| 03/30/2006 | WO2006011137A3 Novel bacteria and pharmaceutically active products obtained therefrom |
| 03/30/2006 | WO2005068612A3 Human hepatic progenitor cells and methods of use thereof |
| 03/30/2006 | WO2005018342A8 Compositions and methods for the maintenance of oral health |
| 03/30/2006 | WO2004087893A9 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069057 Medicaments containing xenogeneic oligo- and/or polyribonucleotides |
| 03/30/2006 | US20060069054 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/30/2006 | US20060069053 Methods and compositions for enhancing cartilage repair |
| 03/30/2006 | US20060068495 Process of cell electrofusion |
| 03/30/2006 | US20060068484 Enteropathogenic E. Coli is a separate genus pathogenic bacteria |
| 03/30/2006 | US20060068047 Adsorbent for endocrine disruptors and foods and drinks containing the same |
| 03/30/2006 | US20060068022 Bioactive agent compositions for repair of cell injuries |
| 03/30/2006 | US20060068004 Buccal delivery of sea cucumber tablets |
| 03/30/2006 | US20060067986 Mixture of milk, protein such as casein and enzyme inhibiting peptide |
| 03/30/2006 | US20060067983 Stand-alone film and methods for making the same |
| 03/30/2006 | US20060067974 Drug delivery coating for use with a stent |
| 03/30/2006 | US20060067949 Immunization with porphyromonas gingivalis protects against heart disease |
| 03/30/2006 | US20060067948 Viral vectors |
| 03/30/2006 | US20060067946 Method of treatment using ligand-immunogen conjugates |
| 03/30/2006 | US20060067924 Probiotic bacteria and methods |
| 03/30/2006 | US20060067923 Preventing agent against drug-resistant bacterial infection |
| 03/30/2006 | US20060067922 Low water activity nutritional product having beneficial microbial and high oil content |
| 03/30/2006 | US20060067921 Probiotic bacterium: lactobacillus fermentum |
| 03/30/2006 | US20060067918 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
| 03/30/2006 | US20060067917 Insulin delivery system |
| 03/30/2006 | US20060067916 Sperm cell process system |
| 03/30/2006 | US20060067914 Immortalized natural killer cell line |
| 03/30/2006 | US20060067912 Methods for the induction of professional and cytokine-producing regulatory T cells |
| 03/30/2006 | US20060067897 Process for the preparation of an extract with Carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium |
| 03/30/2006 | DE10105420B4 In vitro Zellinteraktionskultursystem für Medikamententestung und -entwicklung In vitro cell culture system for drug interaction testing and development |
| 03/30/2006 | CA2580975A1 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| 03/30/2006 | CA2580754A1 Compositions and methods for stem cell expansion and differentiation |
| 03/30/2006 | CA2580616A1 Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton |
| 03/30/2006 | CA2580192A1 Pharmaceutical product containing blood constituents and or kda, and the use of the same for the prophylaxis and treatment of defects of the immune system |
| 03/30/2006 | CA2578736A1 Strain of lactobacillus acidophilus having analgesic properties in the gastrointestinal system |
| 03/30/2006 | CA2521421A1 C-mycer.tam. induced human neural stem cell lines |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640716A1 Blood cell separation membrane and blood retention tool including the same |
| 03/29/2006 | EP1640447A1 BIOACTIVE PEPTIDE-PRODUCING STRAINS OF i ENTEROCOCCUS FAECALIS /i , BIOACTIVE PEPTIDES AND APPLICATIONS THEREOF |
| 03/29/2006 | EP1640024A2 Cell-coated support |
| 03/29/2006 | EP1640013A2 Inactivated Salmonella vaccines |
| 03/29/2006 | EP1640012A1 Pharmaceuticals agents comprising blood components 10 kDa and their use for prophylaxis and treatment of defects of the immune system |
| 03/29/2006 | EP1639509A2 Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 03/29/2006 | EP1639097A2 Methods and compositions for modulating stem cell growth and differentiation |
| 03/29/2006 | EP1639096A2 Methods of producing neurons |
| 03/29/2006 | EP1639001A1 Method for transplanting lymphohematopoietic cells into mammal |
| 03/29/2006 | EP1638583A1 Leukocyte cell banks |
| 03/29/2006 | EP1638581A2 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 03/29/2006 | EP1638561A1 Sponge toxins |
| 03/29/2006 | EP1638547A1 Composition for preventing urinary system infections |
| 03/29/2006 | EP1638513A1 High unsaponifiables and methods of using the same |
| 03/29/2006 | EP1638416A2 Nutritional formula for optimal gut barrier function |
| 03/29/2006 | EP1638415A1 Infant or follow-on formula |
| 03/29/2006 | EP1638414A1 Infant or follow-on formula |
| 03/29/2006 | EP1523311B1 Calcium lactate and whey permeate for lowering the triglyceride level |